INNERCAP Granted Patent for Multi-Phase, Multi-Compartment Capsular Delivery Apparatus
INNERCAP Technologies, Inc., a combination drug delivery system company, recently announced the grant of US Patent No. 8,361,497 B2 titled Multi-Phase, Multi-Compartment Capsular Delivery Apparatus. The delivery system has uses for biopharmaceutical, pharmaceutical, medical foods, and nutraceutical products. In addition to the existing US, Canadian, Australian, and New Zealand patents, this patent covers the company’s multi-phase, multi-compartment delivery system used to enable the development of multi-compartment, multi-phase delivery forms of combination products that have compatibility, formulation, or targeted delivery requirements.
“This is a significant development for INNERCAP Technologies NOVACAP delivery system technology,” said Fred H. Miller, Chief Executive Officer at INNERCAP. “The continued growth of our patent portfolio establishes INNERCAP as one of the leading delivery system companies in this unique space for combination products.”
The delivery system and combinations covered by the patent have the ability to deliver therapeutic entities that have never been combined previously and now can be administered together, via an oral, implanted, or suppository capsule, in the most advantageous pharmacokinetic profile, utilizing different physical phases. This technology can therefore be used to enable capsule administration of compounds that are not administered as a combination product. The efficacy, safety, and side-effect profiles of drugs can be substantially improved using this delivery technology. It will also provide very significant quality-of-life improvements for patients and substantial economic savings for hard-pressed healthcare systems.
“INNERCAP’s multi-phase, multi-compartment technology has been commercially manufactured and validated in several products, demonstrating that INNERCAP’s delivery system creates real value to consumers and branded manufacturers,” added Mr. Miller.
INNERCAP was represented by Cliff Davidson, Esq. of the patent firm Davidson, Davidson & Kappel, LLC based in New York City.
For more information, contact: INNERCAP Technologies, Inc.; 9216 Palm River Road, Suite 203; Tampa, Florida 33619; T: (813) 837-0796; Email: businessdevelopment@innercap.com; Website: www.innercap.com.
Total Page Views: 1179
